Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. [electronic resource] by
- Guo, Deliang
- Prins, Robert M
- Dang, Julie
- Kuga, Daisuke
- Iwanami, Akio
- Soto, Horacio
- Lin, Kelly Y
- Huang, Tiffany T
- Akhavan, David
- Hock, M Benjamin
- Zhu, Shaojun
- Kofman, Ava A
- Bensinger, Steve J
- Yong, William H
- Vinters, Harry V
- Horvath, Steve
- Watson, Andrew D
- Kuhn, John G
- Robins, H Ian
- Mehta, Minesh P
- Wen, Patrick Y
- DeAngelis, Lisa M
- Prados, Michael D
- Mellinghoff, Ingo K
- Cloughesy, Timothy F
- Mischel, Paul S
Producer: 20100305
In:
Science signaling vol. 2
Availability: No items available.
|
|
5.
|
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. [electronic resource] by
- Gini, Beatrice
- Zanca, Ciro
- Guo, Deliang
- Matsutani, Tomoo
- Masui, Kenta
- Ikegami, Shiro
- Yang, Huijun
- Nathanson, David
- Villa, Genaro R
- Shackelford, David
- Zhu, Shaojun
- Tanaka, Kazuhiro
- Babic, Ivan
- Akhavan, David
- Lin, Kelly
- Assuncao, Alvaro
- Gu, Yuchao
- Bonetti, Bruno
- Mortensen, Deborah S
- Xu, Shuichan
- Raymon, Heather K
- Cavenee, Webster K
- Furnari, Frank B
- James, C David
- Kroemer, Guido
- Heath, James R
- Hege, Kristen
- Chopra, Rajesh
- Cloughesy, Timothy F
- Mischel, Paul S
Producer: 20140519
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|